The ApoB 100-Apo(a) Complex: Relation to Triglyceride-Rich Particles

  • Angelo M. Scanu
  • Gunther Fless
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 285)


Lipoprotein(a) is one of the plasma lipoproteins with general characteristics of LDL but having as a protein moiety apoB100 linked by disulfide bridge(s) to apolipoprotein(a) or apo(a), the specific glycoprotein marker of Lp(a) (1–3). Thus, the protein moiety of Lp(a) is the apoB100-apo(a) complex. We will here examine the physico-chemical properties of this complex and try to relate them to its function.


Plasma Lipoprotein Familial Hypercholesterolemia Protein Moiety Partial Amino Acid Sequence Human Apolipoprotein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    A.M. Scanu, L. Scandiani. Lipoprotein^) structure, biology and clinical relevance. Adv. in Intern. Med., In press (1990)Google Scholar
  2. 2.
    A.M. Scanu, G.M. Fless. Lipoprotein(a) heterogeneity and biological relevance. J.Clin. Invest. In press (1990).Google Scholar
  3. 3.
    G. Utermann. The mysteries of Lipoprotein(a). Science 246:904–910 (1989).PubMedCrossRefGoogle Scholar
  4. 4.
    C.Y. Yang, L. Chan, A.M. Gotto Jr. The complete structures of human apolipoprotein B-100 and its messenger RNA. In Plasma lipoproteins. A.M. Gotto, Jr. editor. Elsevier, Amsterdam, New York, Oxford. 77–93 (1987).CrossRefGoogle Scholar
  5. 5.
    R.D. Coleman, T.W. Kim, A.M. Gotto, Jr., C.Y. Yang. Determination of systeine on low-density lipoproteins using the fluorescent probe, 5 -iodoacetamidofluoresceine. Biochim. Biophys. Acta. 1037:129–132 (1990).PubMedCrossRefGoogle Scholar
  6. 6.
    G.M. Fless, D.J. Pfaffinger, J.D. Eisenbart, A.M. Scanu. Solubilty, immunochemical, and lipoprotein binding properties of apoB-100-apo(a), the Protein moiety of Lipoprotein(a). J. Lipid. Res. In press (1990).Google Scholar
  7. 7.
    S.L. Frank, I. Klisak, R.S. Sparkes, T. Mohandas, J.E. Tomlinson, J.W. McLean, R.M. Lawn, A.J. Lusis. The apolipoprotein(a) gene resides on human chromosome 6q26–27, in close proximity to the homologous gene for plasminogen. Hum. Genet. 79:352–356 (1988).PubMedCrossRefGoogle Scholar
  8. 8.
    G. Lindhal, E. Gersdorf, H.J. Menael, C. Duba, H. Cleve, S. Humphries, G. Utermann. The gene for the Lp(a)-specific glycoprotein is closely linked to the gene for plasminogen on chromosome 6. Hum. Genet. 81:149–152 (1989).CrossRefGoogle Scholar
  9. 9.
    D.L. Eaton, G.M. Fless, W.J. Kohr, J.W. McLean, Q.Xu, C.G. Miller, R.M. Lawn, A.M. Scanu. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. 84:3224–3228 (1987).Google Scholar
  10. 10.
    J.W. McLean, J.E. Tomlinson, W. Kuang, D.L. Eaton, E.Y. Chen, CM. Fless, A.M. Scanu, R.M. Lawn. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330:132–137 (1987).PubMedCrossRefGoogle Scholar
  11. 11.
    R.M. Lawn, J.E. Tomlinson, J.W. McLean, D.L. Eaton. Molecular biology of apolipoprotein(a). In Lipoprotein(a): 25 years of progress. A.M. Scanu, editor. Academis Press Inc., New York, In press (1990).Google Scholar
  12. 12.
    J.E. Hixson, M.L. Britten, G. S. Manis, D.L. Rainwater. Apolipoprotein(a)[Apo(a)] glycoprotein isoforms result from size differences in apo(a) mRNA in baboons. J. Biol. Chem. 264:6013–6016 (1989).PubMedGoogle Scholar
  13. 13.
    J.E. Goldstein, M.S. Brown. In The Metabolic Basis of Inherited Disease, eds. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle. MCGraw-Hill Co, NY, 6:1215 -1250(1989).Google Scholar
  14. 14.
    K.A. Hajjar, D. Gavish, J.L. Breslow, R.L. Nachman. Lipoprotein(a) modulation endohelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature. 339:303–305 (1989).PubMedCrossRefGoogle Scholar
  15. 15.
    L.M. Powell, G. Rice, R. Lawn, E. Eaton. Binding of Lp(a) and recombinant apo(a) to the mouse macrophage cell line P388D.1. Atherosclerosis, 701a (1989).Google Scholar
  16. 16.
    G.M. Fless. Heterogeneity of particles containing the apoB-apo(a) complex. In Lipoprotein(a): 25 years of progress. A.M. Scanu, editor. Academic Press Inc. NY, In press (1990).Google Scholar
  17. 17.
    J. Loscalzo, G.M. Fless, A.M. Scanu. Lp(a) and the fibrinolytic system. In Lipoprotein(a): 25 years of progress. A.M. Scanu, editor. Academic Press Inc. NY, In press (1990).Google Scholar
  18. 18.
    E.F. Plow, L.A. Miles. Relationship between plasminogen receptors and Lp(a). In Lipoprotein(a): 25 years of progress. A.M. Scanu, editor. Academic Press Inc. NY, In press (1990).Google Scholar
  19. 19.
    M. Gonzalez-Gronow, J.M. Edelberg, S.V. Pizzo. Further characterization of the cellular plasminogen binding site; evidence that plasminogen 2 and lipoprotein a compete for the same site. Biochemistry, 28:2374–2377 (1989).PubMedCrossRefGoogle Scholar
  20. 20.
    J.M. Edelberg, M. Gonzalez-Gronow, S.V. Pizzo. Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator. Throm. Res. 57:155–162 (1990).CrossRefGoogle Scholar
  21. 21.
    R.S. Elkeles, R. Chakrabarti, M. Vickers, Y. Stirling, T.W. Meade. Effect of treatment of hyperlipidaemia on haemostatic variables. Br. Med. J. 281:973–974 (1980).PubMedCrossRefGoogle Scholar
  22. 22.
    H.C.R. Simpson, J.I. Mann, T.W. Maede, R. Chakrabarti, Y. Stirling, L. Woolf. Hypertriglyceridaemia and hypercoagulability. Lancet, i:786–790 (1983).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Angelo M. Scanu
    • 1
  • Gunther Fless
    • 1
  1. 1.Departments of Medicine, Biochemistry and Molecular BiologyThe University of ChicagoChicagoUSA

Personalised recommendations